At Ironwood, we are committed to finding new treatments for patients living with GI diseases
Who is Ironwood?
Our vision is clear: bring new, differentiated therapies to the millions of patients who live with GI diseases.
Our in-market product, LINZESS® (linaclotide), discovered in-house, is the branded prescription market leader in its class.
We believe we have what it takes to achieve our vision and we’re all in. Together, we’re paving a path to long-term success.
“I am excited about the opportunity to be GI-focused and to bring exciting new therapies to our trusted GI community.”Robin May, Clinical Sales Specialist, Jefferson City, MO
“Everyone at Ironwood is a true owner of the company. The ownership mindset extends beyond the home office and out into the field sales organization. Being an owner, I am interested in the entire company doing well, not just myself or my team.”Stacy Pokrywka, Regional Sales Manager, Great Lakes